{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:22:36Z","timestamp":1782915756216,"version":"3.54.5"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Antimicrobial reistance (AMR) is one of the biggest threats to global public health. Selection of resistant bacteria is driven by inappropriate use of antibiotics, amongst other factors. COVID-19 may have exacerbated AMR due to unnecessary antibiotic prescribing. Country-level knowledge is needed to understand options for action.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To review AMR in Russia and any initiatives addressing it. Identifying any areas where more information is required will provide a call to action to minimize any further rise in AMR within Russia and to improve patient outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>National AMR initiatives, antibiotic use and prescribing, and availability of susceptibility data, in particular for the key community-acquired respiratory tract infection (CA-RTI) pathogens Streptococcus pneumoniae and Haemophilus influenzae, were identified. National and international antibiotic prescribing guidelines commonly used locally for specific CA-RTIs (community-acquired pneumonia, acute otitis media and acute bacterial rhinosinusitis) were also reviewed, plus local antibiotic availability. Insights from both a local clinician and a local clinical microbiologist were sought to contextualize this information.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Russia launched a national strategy in 2017 to prevent the spread of AMR and the WHO reports that as of 2020\u201321, it is being implemented and actively monitored. Reports suggest outpatient antibiotic use of antibiotics is high and that non-prescription access and self-medication are very common. Antibiotic susceptibility studies in Russia include PeHASus, a multicentre epidemiological study focusing on susceptibilities of community-acquired respiratory pathogens and international studies such as Survey of Antibiotic Resistance (SOAR), Antimicrobial Testing Leadership and Surveillance (ATLAS) and SENTRY Antimicrobial Surveillance Program. International guidelines are used to support the development of local guidelines in Russia, and for the common CA-RTIs Russian clinicians use of several country-specific local antibiotic prescribing guidelines. A standardized inclusive approach in developing local guidelines, using up-to-date surveillance data of isolates from community-acquired infections in Russia, could make guideline use more locally relevant for clinicians. This would pave the way for a higher level of appropriate antibiotic prescribing and improved adherence. This would, in turn, potentially limit AMR development and improve patient outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkac218","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T08:09:09Z","timestamp":1662451749000},"page":"i61-i69","source":"Crossref","is-referenced-by-count":7,"title":["Country data on AMR in Russia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome"],"prefix":"10.1093","volume":"77","author":[{"given":"Didem","family":"Torumkuney","sequence":"first","affiliation":[{"name":"GlaxoSmithKline , 980 Great West Road, Brentford, Middlesex TW8 9GS , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Kozlov","sequence":"additional","affiliation":[{"name":"Smolensk State Medical University (SSMU) , Krupskaya Str. 28 Smolensk 214019 , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Sidorenko","sequence":"additional","affiliation":[{"name":"Pediatric Research and Clinical Centre for Infectious Diseases , Professor Popov Str. 9 , Russia"},{"name":"North Western State Medical University named after I. I. Mechnikov, Kirochnaya Str. 41 , St Petersburg 195067 , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Kamble","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline , 252, Dr Annie Besant Road, Worli, 400030, Mumbai , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Lezhnina","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Trading , Leningrad\u2019s prospect, 37A, bld. 4, Arcus III, 125167 Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Galushkin","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Trading , Leningrad\u2019s prospect, 37A, bld. 4, Arcus III, 125167 Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhashri","family":"Kundu","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline , 23 Rochester Park, 139234 , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"2022090713493260500_dkac218-B1","article-title":"Antibiotic resistance \u2013 fact sheet","author":"WHO","year":"2020"},{"key":"2022090713493260500_dkac218-B2","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkac211","article-title":"Relevance of the Consensus Principles for Appropriate Antibiotic Prescribing in 2022","volume":"77","author":"Cant\u00f3n","year":"2022","journal-title":"J Antimicrobial Chemother"},{"key":"2022090713493260500_dkac218-B3","article-title":"Antimicrobial resistance \u2013 fact sheet","author":"WHO","year":"2021"},{"key":"2022090713493260500_dkac218-B4","article-title":"Global action plan on antimicrobial resistance","author":"WHO","year":"2015"},{"key":"2022090713493260500_dkac218-B5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/1467-9566.13224","article-title":"Obligatory medical prescription of antibiotics in Russia: Navigating formal and informal health-care infrastructures","volume":"43","author":"Kamenschikova","year":"2021","journal-title":"Sociol Health Illn"},{"key":"2022090713493260500_dkac218-B6","article-title":"Approval of the strategy to prevent the spread of antimicrobial resistance","author":"Ministry of Health of the Russian Federation"},{"key":"2022090713493260500_dkac218-B7","article-title":"Global Database for the Tripartite Antimicrobial Resistance (AMR) Country Self-assessment Survey (TrACSS)","author":"WHO\/OIE\/FAO"},{"key":"2022090713493260500_dkac218-B8","article-title":"WHO report on surveillance of antibiotic consumption, 2016-2018 early implementation","author":"WHO","year":"2018"},{"key":"2022090713493260500_dkac218-B9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40360-017-0116-y","article-title":"Antibiotic use practices of pharmacy staff: a cross-sectional study in Saint Petersburg, the Russian Federation","volume":"18","author":"Belkina","year":"2017","journal-title":"BMC Pharmacol Toxicol"},{"key":"2022090713493260500_dkac218-B10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.36488\/cmac.2019.3.230-237","article-title":"Antimicrobial resistance of clinical Streptococcus pneumoniae isolates in Russia: the results of multicenter epidemiological study PeHASus 2014\u20132017","volume":"21","author":"Ivanchik","year":"2019","journal-title":"Clin Microbiol Antimicrob Chemother"},{"key":"2022090713493260500_dkac218-B11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.36488\/cmac.2019.4.317-323","article-title":"Antimicrobial resistance of clinical Haemophilus influenzae isolates in Russia: the results of multicenter epidemiological study PeHASus 2014\u20132017","volume":"21","author":"Ivanchik","year":"2019","journal-title":"Clin Microbiol Antimicrob Chemother"},{"key":"2022090713493260500_dkac218-B12","doi-asserted-by":"crossref","first-page":"620002","DOI":"10.3389\/fmicb.2021.620002","article-title":"AMRmap: an interactive web platform for analysis of antimicrobial resistance surveillance data in Russia","volume":"12","author":"Kuzmenkov","year":"2021","journal-title":"Front Microbiol"},{"issue":"Suppl 5","key":"2022090713493260500_dkac218-B13","doi-asserted-by":"crossref","first-page":"v14","DOI":"10.1093\/jac\/dky065","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2014\u201316 in Russia","volume":"73","author":"Torumkuney","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2022090713493260500_dkac218-B14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/CMR.00047-06","article-title":"Setting and revising antibacterial susceptibility breakpoints","volume":"20","author":"Turnidge","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"2022090713493260500_dkac218-B15","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cmi.2019.03.007","article-title":"Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance","volume":"25","author":"Cusack","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2022090713493260500_dkac218-B16","article-title":"Implementation of EUCAST breakpoints\/guidelines","author":"EUCAST","year":"2022"},{"key":"2022090713493260500_dkac218-B17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in Europe","volume":"67","author":"Welte","year":"2010","journal-title":"Thorax"},{"key":"2022090713493260500_dkac218-B18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U. S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"2022090713493260500_dkac218-B19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1470-9465.2004.00862.x","article-title":"Building in efficacy: developing solutions to combat drug-resistant S. pneumoniae","volume":"10","author":"Jacobs","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"2022090713493260500_dkac218-B20","article-title":"Antimicrobial surveillance","author":"Pfizer"},{"key":"2022090713493260500_dkac218-B21","article-title":"JMI Laboratories"},{"key":"2022090713493260500_dkac218-B22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.35772\/ghm.2019.01026","article-title":"Strategic approach for combating antimicrobial resistance (AMR)","volume":"1","author":"Inoue","year":"2019","journal-title":"Global Health Med"},{"key":"2022090713493260500_dkac218-B23","article-title":"Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report. Early implementation","author":"WHO","year":"2020"},{"key":"2022090713493260500_dkac218-B24","article-title":"Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2021","author":"WHO","year":"2021"},{"key":"2022090713493260500_dkac218-B25","article-title":"Global Antimicrobial Resistance and Use Surveillance System","author":"WHO"},{"key":"2022090713493260500_dkac218-B26","article-title":"Community-acquired pneumonia in children. Clinical guidelines","author":"Astrakhan State Medical University","year":"2015"},{"key":"2022090713493260500_dkac218-B27","article-title":"Clinical guidelines: Otitis media acute, ID314","author":"National Medical Association of Otorhinolaryngologists","year":"2021"},{"key":"2022090713493260500_dkac218-B28","article-title":"Clinical guidelines: Acute sinusitis, ID313","author":"National Medical Association of Otorhinolaryngologists","year":"2021"},{"key":"2022090713493260500_dkac218-B29","article-title":"Clinical guidelines: Community-acquired pneumonia, adults, ID314","author":"Russian Respiratory Society","year":"2021"},{"key":"2022090713493260500_dkac218-B30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/49.1.31","article-title":"Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence","volume":"49","author":"Ball","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"2022090713493260500_dkac218-B31","article-title":"Access barriers to antibiotics","author":"Frost","year":"2019"},{"key":"2022090713493260500_dkac218-B32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2471\/BLT.17.199562","article-title":"Medicines quality assurance to fight antimicrobial resistance","volume":"96","author":"Nwokike","year":"2018","journal-title":"Bull World Health Organ"},{"key":"2022090713493260500_dkac218-B33","article-title":"Substandard and falsified medical products","author":"WHO"},{"key":"2022090713493260500_dkac218-B34","doi-asserted-by":"crossref","first-page":"dlaa053","DOI":"10.1093\/jacamr\/dlaa053","article-title":"The impact of the COVID-19 pandemic on antimicrobial resistance: a debate","volume":"2","author":"van Duin","year":"2020","journal-title":"JAC Antimicrob Resist"},{"key":"2022090713493260500_dkac218-B35","doi-asserted-by":"crossref","first-page":"dlaa049","DOI":"10.1093\/jacamr\/dlaa049","article-title":"PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates","volume":"2","author":"Clancy","year":"2020","journal-title":"JAC Antimicrob Resist"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/Supplement_1\/i61\/45740919\/dkac218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/Supplement_1\/i61\/45740919\/dkac218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T13:49:57Z","timestamp":1662558597000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/77\/Supplement_1\/i61\/6692271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":35,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2022,9,6]]},"published-print":{"date-parts":[[2022,9,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkac218","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,6]]},"published":{"date-parts":[[2022,9,6]]}}}